Robarts president awarded Queens Golden Jubi

Robarts president awarded Queens Golden Jubilee Medal

LONDON, ON (Dec. 20, 2002) Dr. Mark Poznansky was honoured this week as a recipient of The Queens Golden Jubilee Medal, which is awarded to those who have made a significant contribution to Canada, and their community or fellow Canadians.

The Queen announced the new annual award in spring, marking the 50th anniversary of her accession to the throne, to recognize the vital role played by the hundreds of thousands of unsung heroes of the community and voluntary world. Up to 200 awards were to be bestowed in the first year out of more than 1,400 nominations across the United Kingdom.

It is certainly an honour to be recognized by the Queen in such distinguished company, Dr. Poznansky said following the ceremony in London. Among the 28 individuals and groups honoured this week were community volunteer Nancy McNee, also a member of Robarts Council; businessman and philanthropist Geno Francolini; Dr. Paul Davenport, President of The University of Western Ontario; and Tony Dagnone, President and CEO of London Health Sciences Centre.

In addition to his role as President & Scientific Director at Robarts Research Institute, Dr. Poznansky is a founder of London Biotechnology Incubator Inc., and a founding member and past chair of the Council for Health Research in Canada, a research advocacy group in Ottawa. He also chairs the Scientific Advisory Board of the Canadian Medical Discoveries Fund and sits on numerous biotechnology-industry related boards. Dr. Poznansky continues to lecture widely, both nationally and internationally, in the areas of bioethics and research administration and funding, including technology transfer.

A native of Montreal, Dr. Poznansky was educated at McGill University, receiving his PhD in Physiology and completing postdoctoral training in Biophysics at Harvard Medical School, where he held the position of Lecturer in Biophysics before coming to Canada as Associate Professor of Physiology at the University of Alberta in Edmonton.

Over the next 18 years, Dr. Poznansky rose to the rank of Professor his laboratory developed an international reputation both in the areas of cholesterol and membrane biophysics as well as enzyme replacement therapy and the development of novel approaches to drug delivery and he went on to become Associate Dean of Medicine in charge of research before joining Robarts in 1993.

--30--